Trial Profile
An Open-label Multicenter 12-month Long Term Study on Skin Reconstitution With Pimecrolimus Cream 1% in Adult Patients With Atopic Eczema and Corticosteroid Induced Skin Damage
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Pimecrolimus (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Novartis
- 28 Mar 2016 New trial record